Published in Brain Res on July 10, 2012
Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis (2013) 1.62
A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci Rep (2014) 1.38
Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier. BMC Neurosci (2013) 0.94
A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells. Brain Res (2013) 0.93
Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells. PLoS One (2014) 0.90
In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. J Cereb Blood Flow Metab (2016) 0.90
Modeling the blood-brain barrier using stem cell sources. Fluids Barriers CNS (2013) 0.86
A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1. PLoS One (2013) 0.86
Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport. J Vis Exp (2014) 0.85
In vitro cerebrovascular modeling in the 21st century: current and prospective technologies. Pharm Res (2014) 0.84
Ability of the Encephalitic Arbovirus Semliki Forest Virus To Cross the Blood-Brain Barrier Is Determined by the Charge of the E2 Glycoprotein. J Virol (2015) 0.81
A multi-system approach assessing the interaction of anticonvulsants with P-gp. PLoS One (2013) 0.80
A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug. PLoS One (2014) 0.78
A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes. PLoS One (2015) 0.77
Permeability across a novel microfluidic blood-tumor barrier model. Fluids Barriers CNS (2017) 0.75
The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro. Brain Res (2016) 0.75
Bidirectional apical-basal traffic of the cation-independent mannose-6-phosphate receptor in brain endothelial cells. J Cereb Blood Flow Metab (2017) 0.75
Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci (2006) 12.23
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol (2001) 9.62
Structure and function of the blood-brain barrier. Neurobiol Dis (2009) 7.64
Pericytes regulate the blood-brain barrier. Nature (2010) 6.62
Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature (2010) 5.47
Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J (2005) 5.46
Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron (2010) 5.20
Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol (2006) 3.13
Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol (2002) 2.94
Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat (2002) 2.88
Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol (2005) 2.58
A cell culture model of the blood-brain barrier. J Cell Biol (1991) 2.35
Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov (2007) 2.19
Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem (2005) 2.14
A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int (2008) 2.06
ABC transporters and the blood-brain barrier. Curr Pharm Des (2004) 1.92
Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol (2008) 1.59
Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J Cell Physiol (1994) 1.55
Brain microvessel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability. Ann Neurol (1983) 1.53
Brain endothelial cells and the glio-vascular complex. Cell Tissue Res (2008) 1.53
Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr (2006) 1.50
Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci (1992) 1.50
In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev (1999) 1.49
CNS delivery via adsorptive transcytosis. AAPS J (2008) 1.46
In vitro models for the blood-brain barrier. Toxicol In Vitro (2005) 1.41
The critical component to establish in vitro BBB model: Pericyte. Brain Res Brain Res Rev (2005) 1.32
Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. J Pharm Sci (2001) 1.31
Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J Physiol (2005) 1.30
Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies. Brain Res (2003) 1.28
Collagen as a substrate for cell growth and differentiation. Methods Enzymol (1982) 1.28
African trypanosome interactions with an in vitro model of the human blood-brain barrier. J Parasitol (2004) 1.27
Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro. Brain Res Brain Res Protoc (2000) 1.27
Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur J Pharm Sci (2001) 1.26
Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Exp Cell Res (2003) 1.22
Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions. Cell Mol Neurobiol (2005) 1.19
Physiology of rat retinal pericytes: modulation of ion channel activity by serum-derived molecules. J Physiol (1999) 1.17
Transport of interleukin-1 across cerebromicrovascular endothelial cells. Br J Pharmacol (2009) 1.12
A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Brain Res (2007) 1.11
Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem Biophys Res Commun (1999) 1.11
An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res (1999) 1.11
Angiogenesis of the blood-brain barrier in vitro and the function of cerebral pericytes. FASEB J (2002) 1.11
Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood-brain barrier function. J Cell Physiol (2010) 1.08
Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. Biochem Biophys Res Commun (1998) 1.08
Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult. J Cereb Blood Flow Metab (2010) 1.08
High transcytosis of melanotransferrin (P97) across the blood-brain barrier. J Neurochem (2002) 1.07
Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. Exp Cell Res (2004) 1.02
Serum-derived factors weaken the barrier properties of cultured porcine brain capillary endothelial cells in vitro. Brain Res (2003) 0.98
An overview of in vitro techniques for blood-brain barrier studies. Methods Mol Med (2003) 0.97
Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro. Endothelium (2008) 0.96
Synergistic effects of neurons and astrocytes on the differentiation of brain capillary endothelial cells in culture. J Cell Mol Med (2003) 0.96
Pathophysiology of the blood-brain barrier: animal models and methods. Curr Top Dev Biol (2008) 0.96
Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models. Drug Discov Today Technol (2004) 0.95
Effect of astroglial cells on hypoxia-induced permeability in PBMEC cells. Am J Physiol Cell Physiol (2000) 0.94
Blood-brain barrier transport of caffeine: dose-related restriction of adenine transport. Life Sci (1982) 0.92
Blood-brain barrier imaging and therapeutic potentials. Top Magn Reson Imaging (2006) 0.92
Primary porcine brain microvascular endothelial cells: biochemical and functional characterisation as a model for drug transport and targeting. J Drug Target (2007) 0.91
The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? Pharmacol Res (2010) 0.91
Murine in vitro model of the blood-brain barrier for evaluating drug transport. Eur J Pharm Sci (2010) 0.90
Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability. Drug Metab Dispos (2006) 0.89
Blood-brain barrier characteristic enzymatic properties in cultured brain capillary endothelial cells. Brain Res (1990) 0.89
Human blood-derived macrophages enhance barrier function of cultured primary bovine and human brain capillary endothelial cells. J Physiol (2003) 0.89
The susceptibility of cerebral endothelial cells to astroglial induction of blood-brain barrier enzymes depends on their proliferative state. J Neurochem (1991) 0.88
Synergistic stimulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities by retinoic acid and astroglial factors in immortalized rat brain microvessel endothelial cells. J Cell Physiol (1996) 0.87
Morphology and properties of astrocytes. Methods Mol Biol (2011) 0.86
Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE4. J Neurochem (1996) 0.86
The complementary membranes forming the blood-brain barrier. IUBMB Life (2002) 0.86
Alterations in transendothelial electrical resistance by vasoactive agonists and cyclic AMP in a blood-brain barrier model system. Neurochem Res (1998) 0.85
Induction of the blood/brain-barrier-associated enzyme alkaline phosphatase in endothelial cells from cerebral capillaries is mediated via cAMP. Eur J Biochem (1995) 0.83
Evaluation of blood-brain barrier transporters by co-culture of brain capillary endothelial cells with astrocytes. Drug Metab Pharmacokinet (2002) 0.83
Blood-brain barrier in vitro models and their application in toxicology. The report and recommendations of ECVAM Workshop 49. Altern Lab Anim (2004) 0.80
Methods to assess pericyte-endothelial cell interactions in a coculture model. Methods Mol Biol (2011) 0.79
A porcine astrocyte/endothelial cell co-culture model of the blood-brain barrier. Brain Res Brain Res Protoc (2003) 0.79
Strategies to advance translational research into brain barriers. Lancet Neurol (2008) 2.16
Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res (2005) 1.65
Role of sarA in the pathogenesis of Staphylococcus aureus musculoskeletal infection. Infect Immun (2003) 1.60
Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med (2004) 1.57
Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res (2002) 1.46
Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology (2006) 1.41
Bone formation is impaired in a model of type 1 diabetes. Diabetes (2005) 1.32
Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem (2003) 1.25
Induction of aquaporin 1 but not aquaporin 4 messenger RNA in rat primary brain microvessel endothelial cells in culture. J Neurochem (2005) 1.24
The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res (2002) 1.21
Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease. Am J Pathol (2008) 1.19
sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates. Mol Microbiol (2012) 1.08
Immunohistochemical study of osteopontin expression during distraction osteogenesis in the rat. J Histochem Cytochem (2002) 1.07
Aging alters the skeletal response to disuse in the rat. Am J Physiol Regul Integr Comp Physiol (2006) 1.06
A novel mouse model for the study of the inhibitory effects of chronic ethanol exposure on direct bone formation. Alcohol (2006) 1.02
Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res (2010) 0.97
An overview of in vitro techniques for blood-brain barrier studies. Methods Mol Med (2003) 0.97
Early detection of bone infection and differentiation from post-surgical inflammation using 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography (FDG-PET) in an animal model. J Orthop Res (2005) 0.97
In vitro trans-monolayer permeability calculations: often forgotten assumptions. Drug Discov Today (2003) 0.96
All vertebrates started out with a glial blood-brain barrier 4-500 million years ago. Glia (2008) 0.96
Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: role of the TNF signaling axis. Toxicol Appl Pharmacol (2007) 0.95
A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells. Brain Res (2013) 0.93
Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy. Curr Drug Targets (2003) 0.93
Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis. J Pharmacol Exp Ther (2002) 0.93
Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood-brain barrier. Brain Res (2002) 0.93
Chronic ethanol consumption inhibits postlactational anabolic bone rebuilding in female rats. J Bone Miner Res (2008) 0.92
Ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis: a role for the tumor necrosis factor signaling axis. Alcohol Clin Exp Res (2005) 0.89
Skeletal toxicity associated with chronic ethanol exposure in a rat model using total enteral nutrition. J Pharmacol Exp Ther (2002) 0.89
Different molecular mechanisms underlie ethanol-induced bone loss in cycling and pregnant rats. Endocrinology (2005) 0.89
Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. Int J Pharm (2012) 0.87
Chronic ethanol exposure is associated with a local increase in TNF-alpha and decreased proliferation in the rat distraction gap. Cytokine (2003) 0.87
A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1. PLoS One (2013) 0.86
Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat. J Neurochem (2004) 0.86
Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment. PLoS One (2012) 0.86
Functional characterisation of nucleoside transport in rat brain endothelial cells. Neuroreport (2003) 0.85
P-Glycoprotein expression in human retinal pigment epithelium cell lines. Exp Eye Res (2006) 0.85
Use of a B cell marker (B220) to discriminate between allergens and irritants in the local lymph node assay. Toxicol Sci (2002) 0.85
Use of xylitol to enhance the therapeutic efficacy of polymethylmethacrylate-based antibiotic therapy in treatment of chronic osteomyelitis. Antimicrob Agents Chemother (2012) 0.85
Impact of the functional status of saeRS on in vivo phenotypes of Staphylococcus aureus sarA mutants. Mol Microbiol (2014) 0.83
A novel rat model for the study of deficits in bone formation in type-2 diabetes. Acta Orthop (2007) 0.83
Evaluation of dynamic [18F]-FDG-PET imaging for the detection of acute post-surgical bone infection. PLoS One (2012) 0.82
Inhibin A enhances bone formation during distraction osteogenesis. J Orthop Res (2011) 0.82
Blood-brain barrier opened by stimulation of the parasympathetic sphenopalatine ganglion: a new method for macromolecule delivery to the brain. J Neurosurg (2004) 0.82
Cross reactivity of polyclonal GFAP antiserum: implications for the in-vitro characterisation of brain endothelium. Brain Res (2004) 0.81
Cisplatin inhibits bone healing during distraction osteogenesis. J Orthop Res (2013) 0.81
A multi-system approach assessing the interaction of anticonvulsants with P-gp. PLoS One (2013) 0.80
An immortalised astrocyte cell line maintains the in vivo phenotype of a primary porcine in vitro blood-brain barrier model. Brain Res (2012) 0.79
Interaction of nucleoside analogues with nucleoside transporters in rat brain endothelial cells. J Drug Target (2004) 0.79
Sc65 is a novel endoplasmic reticulum protein that regulates bone mass homeostasis. J Bone Miner Res (2014) 0.78
Distraction osteogenesis in TNF receptor 1 deficient mice is protected from chronic ethanol exposure. Alcohol (2011) 0.77
Lipids in blood-brain barrier models in vitro I: Thin-layer chromatography and high-performance liquid chromatography for the analysis of lipid classes and long-chain polyunsaturated fatty acids. In Vitro Cell Dev Biol Anim (2003) 0.77
Lipids in blood-brain barrier models in vitro II: Influence of glial cells on lipid classes and lipid fatty acids. In Vitro Cell Dev Biol Anim (2003) 0.77
Evaluation of the RBE4 cell line to explore carrier-mediated drug delivery to the CNS via the L-system amino acid transporter at the blood-brain barrier. J Drug Target (2002) 0.77
Primary porcine brain microvessel endothelial cell isolation and culture. Curr Protoc Neurosci (2014) 0.75
Ionic currents in isolated and in situ squid Schwann cells. J Physiol (2002) 0.75